ABIVAX: FIRST US PATIENT ENROLLED IN GLOBAL PHASE 3 PROGRAM WITH OBEFAZIMOD IN ULCERATIVE COLITIS Written by Kai Schmitz on 12th October 2022. Posted in Client News. Previous Next